Prostatic Neoplasms
7 competing products in clinical development for Prostatic Neoplasms.
Pipeline by Phase
Pre-clinical2
Phase 11
Phase 23
Phase 31
All Products (7)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Enzalutamide + NSAA + LHRHA or Surgical Castration | Astellas Pharma | Phase 3 | Active | 44 |
| ASP3550 | Astellas Pharma | Phase 2 | Completed | 35 |
| enzalutamide + bicalutamide | Astellas Pharma | Phase 2 | Completed | 35 |
| degarelix | Astellas Pharma | Phase 2 | Completed | 35 |
| Abemaciclib + Darolutamide + LHRH agonist/antagonist | Eli Lilly | Phase 1 | Completed | 29 |
| Novel hormonal therapy | Astellas Pharma | Pre-clinical | Completed | 26 |
| Novel hormonal therapy | Astellas Pharma | Pre-clinical | Completed | 26 |